Company / Depreciation & Amortization
Sonoma Pharmaceuticals, Inc. Depreciation & Amortization History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$138.0K
FY2026
5-year range
$125.0K / $227.0K
FY2022-FY2026
Trend
-21.6%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $125,000 in FY2024 to $490,000 in FY2019.
Based on SEC 10-K filings.
$138,000 in FY2026 with a 5-year CAGR of -15.1%.
Increased from $125,000 to $138,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.1%, indicating a declining trend.
- In FY2026, depreciation & amortization decreased 21.6% year-over-year.
- Peak depreciation & amortization was recorded in FY2019.
- Lowest depreciation & amortization in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $138.0K | -21.6% |
| FY2025 | $176.0K | +40.8% |
| FY2024 | $125.0K | -32.8% |
| FY2023 | $186.0K | -18.1% |
| FY2022 | $227.0K | -27.2% |
| FY2021 | $312.0K | -31.1% |
| FY2020 | $453.0K | -7.6% |
| FY2019 | $490.0K | +97.6% |
| FY2018 | $248.0K | +1.6% |
| FY2017 | $244.0K | -3.6% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026